DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,030.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA Relative Valuation

-210.7%
Upside

As of 2025-02-19, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (42.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -210.7%.

The range of the Relative Valuation is (34.69) - (47.34) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.1x - 34.1x 27.6x
Forward P/E multiples 19.0x - 28.8x 23.9x
Fair Price (34.69) - (47.34) (42.30)
Upside -190.8% - -223.9% -210.7%
38.22 USD
Stock Price
(42.30) USD
Fair Price

DRNA Relative Valuation - Historical P/E Data

Date P/E